PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine A, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky Road, Petah-Tikva 49100, Israel.\', \'Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky Road, Petah-Tikva 49100, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, 39 Klatchkin st., Tel-Aviv 6997801, Israel.\', \'Research Authority, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky Road, Petah-Tikva 49100, Israel.\', \'Unit of Infectious Diseases, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Efron 1 st, Haifa 3200003, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/qjmed/hcab142
?:hasPublicationType
?:journal
  • QJM : monthly journal of the Association of Physicians
is ?:pmid of
?:pmid
?:pmid
  • 34010403
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Tocilizumab in the treatment of COVID-19-a meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all